Pearl Diagnostics, Inc.

New Filing

CIK: 0001922830·Biotechnology·DELAWARE·Filed: Jun 17, 2022

Total Offering

$3,525,000

Amount Sold

$3,525,000

Investors

11

First Sale

Feb 23, 2022

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2022
Non-Accredited Investors: No

Related Persons

Name	Role
Kieren Marr	Related Person
Brad Spellberg	Related Person
John Cammack	Related Person

Company

Pearl Diagnostics, Inc.

1812 ASHLAND AVENUE

BALTIMORE, MD, 21205

410.614.0300

SEC Filing

0001922830-22-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.